TrialEuropean journal of heart failure2022

Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC).

Marco Metra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.